Insmed reports Phase 2b study of brensocatib did not meet efficacy endpoints

Alloy Therapeutics and Biogen expand partnership with multi-target antisense collaboration

Parnell launches first FDA-approved generic florfenicol and flunixin combination for bovine respiratory disease

Innovent and Ollin Biosciences report IBI324 study data in wAMD and DME

Boston Scientific receives FDA clearance for Asurys fluid management system

Lilly presents Phase 3b Taltz (ixekizumab) plus Zepbound (tirzepatide) data at AAD Annual Meeting

Hoth Therapeutics deploys OpenClaw AI platform for drug discovery

Thermo Fisher Scientific and SHL Medical launch integrated US drug-device manufacturing

Sanofi and Regeneron's Dupixent gains Japan approval as first targeted therapy for bullous pemphigoid

Rhythm Pharmaceuticals selects PANTHERx Rare as exclusive US distribution partner for IMCIVREE expanded indication

Bambusa Therapeutics names new CFO

Mabtech partners with Sai Life Sciences to expand access to EYRA multiplex immunology platform

Vimgreen Pharmaceuticals receives IND clearance for VG081821 in China

Inimmune reports dosing of first patient in Phase 2 allergen challenge chamber trial of INI-2004

Gesynta Pharma doses first patient in vipoglanstat Phase 2 clinical proof-of-concept trial